OVERVIEW
Participants will be familiarized with approaches to detect and analyze ctDNA. The clinical benefits and limitations of liquid biopsy-based diagnostics will be discussed.AUDIENCE
This mini symposium targets all scientists and clinicians interested in the field of liquid biopsies, who wish to learn about the benefits and challenges of the approach.AGENDA
09:15 – 09:30 Introduction & Welcome
Tomasz Zemojtel, Head of BIH Genomics Core FacilityGregor Obernosterer, Roche Diagnostics Germany
09:30 – 10:15 Clinical applications and challenges of liquid biopsy
Andre Rosenthal, Signature Diagnostics, Potsdam10:15 – 11:00 Liquid biopsy as a diagnostic tool
Max Ma, Roche Sequencing Solutions, Pleasanton, USA11:00 – 11:30 Bioinformatics challenges in data analyses
Sebastian Froehler, Signature Diagnostics, Potsdam11:30 – 12:00 Open Forum
Please register at events@bihealth.de